Drugs / Shuanghuanglian Oral Liquid
Shuanghuanglian Oral Liquid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06520618 Comparator | Feb 2023 → Feb 2024 | respiratory tract infectious disorder | Shengjing Hospital | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shuanghuanglian Oral Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06520618 ↗ |
| Known as | SHL | “Shuang Huang Lian (SHL) oral liquid” NCT06520618 ↗ |
| Known as | Shuang Huang Lian | “Shuang Huang Lian (SHL) oral liquid” NCT06520618 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “other commercially available TCMs like Shuang Huang Lian (SHL) oral liquid” NCT06520618 ↗ |
| Route | Oral | “Oral administration of Shuanghuanglian Oral Liquid” NCT06520618 ↗ |